Page 270 - Read Online

20. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. 34. Hercher C, Chopra V, Beasley CL. Evidence for morphological
Preferred reporting items for systematic reviews and meta‑analyses: alterations in prefrontal white matter glia in schizophrenia and
the PRISMA statement. Int J Surg 2010;8:336‑41. bipolar disorder. J Psychiatry Neurosci 2014;39:376‑85.
21. Rolstad S, Jakobsson J, Sellgren C, Isgren A, Ekman CJ, 35. Fillman SG, Sinclair D, Fung SJ, Webster MJ, Shannon Weickert C.
Bjerke M, Blennow K, Zetterberg H, Palsson E, Landén M. CSF Markers of inflammation and stress distinguish subsets of individuals
neuroinflammatory biomarkers in bipolar disorder are associated with schizophrenia and bipolar disorder. Transl Psychiatry
with cognitive impairment. Eur Neuropsychopharmacol 2015; 2014;4:e365.
25:1091‑8. 36. de Baumont A, Maschietto M, Lima L, Carraro DM, Olivieri EH,
22. Ishizuka K, Igata‑Yi R, Kimura T, Hieshima K, Kukita T, Kin Y, Fiorini A, Barreta LA, Palha JA, Belmonte‑de‑Abreu P, Moreira
Misumi Y, Yamamoto M, Nomiyama H, Miura R, Takamatsu J, Filho CA, Brentani H. Innate immune response is differentially
Katsuragi S, Miyakawa T. Expression and distribution of CC dysregulated between bipolar disease and schizophrenia. Schizophr
chemokine macrophage inflammatory protein‑1 alpha/LD78 in the Res 2015;161:215‑21.
human brain. Neuroreport 1997;8:1215‑8. 37. Liu L, Li Y, Van Eldik LJ, Griffin WS, Barger SW. S100B‑induced
23. Hamidi M, Drevets WC, Price JL. Glial reduction in amygdala in microglial and neuronal IL‑1 expression is mediated by cell
major depressive disorder is due to oligodendrocytes. Biol Psychiatry type‑specific transcription factors. J Neurochem 2005;92:546‑53.
2004;55:563‑9. 38. Griffin WS. Inflammation and neurodegenerative diseases. Am J
24. Frank O, Giehl M, Zheng C, Hehlmann R, Leib‑Mosch C, Seifarth W. Clin Nutr 2006;83:470S‑4S.
Human endogenous retrovirus expression profiles in samples from 39. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ,
brains of patients with schizophrenia and bipolar disorders. J Virol White CL 3rd, Araoz C. Brain interleukin 1 and S‑100
2005;79:10890‑901. immunoreactivity are elevated in Down syndrome and Alzheimer
25. Dean B, Gray L, Scarr E. Regionally specific changes in levels of disease. Proc Natl Acad Sci U S A 1989;86:7611‑5.
cortical S100beta in bipolar 1 disorder but not schizophrenia. Aust 40. Soderlund J, Olsson SK, Samuelsson M, Walther‑Jallow L,
N Z J Psychiatry 2006;40:217‑24. Johansson C, Erhardt S, Landen M, Engberg G. Elevation of
26. Foster R, Kandanearatchi A, Beasley C, Williams B, Khan N, cerebrospinal fluid interleukin‑1ss in bipolar disorder. J Psychiatry
Fagerhol MK, Everall IP. Calprotectin in microglia from frontal cortex Neurosci 2011;36:114‑8.
is up‑regulated in schizophrenia: evidence for an inflammatory 41. Stich O, Andres TA, Gross CM, Gerber SI, Rauer S, Langosch JM.
process? Eur J Neurosci 2006;24:3561‑6. An observational study of inflammation in the central nervous
27. Weis S, Haybaeck J, Dulay JR, Llenos IC. Expression of cellular prion system in patients with bipolar disorder. Bipolar Disord
protein (PrP (c)) in schizophrenia, bipolar disorder, and depression. 2015;17:291‑302.
J Neural Transm 2008;115:761‑71. 42. Isgren A, Jakobsson J, Palsson E, Ekman CJ, Johansson AG,
28. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity Sellgren C, Blennow K, Zetterberg H, Landen M. Increased
and neuroinflammatory markers in postmortem frontal cortex from cerebrospinal fluid interleukin‑8 in bipolar disorder patients
bipolar disorder patients. Mol Psychiatry 2010;15:384‑92. associated with lithium and antipsychotic treatment. Brain Behav
29. Kim HW, Rapoport SI, Rao JS. Altered arachidonic acid cascade Immun 2015;43:198‑204.
enzymes in postmortem brain from bipolar disorder patients. Mol 43. Haarman BC, Riemersma‑Van der Lek RF, de Groot JC, Ruhe HG,
Psychiatry 2011;16:419‑28. Klein HC, Zandstra TE, Burger H, Schoevers RA, de Vries EF,
30. Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Drexhage HA, Nolen WA, Doorduin J. Neuroinflammation in bipolar
Mawrin C, Brisch R, Bielau H, Meyer zu Schwabedissen L, disorder – A [(11) C]‑(R)‑PK11195 positron emission tomography
Bogerts B, Myint AM. Severe depression is associated with study. Brain Behav Immun 2014;40:219‑25.
increased microglial quinolinic acid in subregions of the anterior 44. Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O,
cingulate gyrus: evidence for an immune‑modulated glutamatergic Spielholz C, Frye R. Clinical trials of N‑acetylcysteine in psychiatry
neurotransmission? J Neuroinflammation 2011;8:94. and neurology: a systematic review. Neurosci Biobehav Rev
31. Rao JS, Keleshian VL, Klein S, Rapoport SI. Epigenetic modifications 2015;55:294‑321.
in frontal cortex from Alzheimer’s disease and bipolar disorder 45. Duncan RE, Bazinet RP. Brain arachidonic acid uptake and turnover:
patients. Transl Psychiatry 2012;2:e132. implications for signaling and bipolar disorder. Curr Opin Clin Nutr
32. Dean B, Gibbons AS, Tawadros N, Brooks L, Everall IP, Scarr E. Metab Care 2010;13:130‑8.
Different changes in cortical tumor necrosis factor‑alpha‑related 46. Rapoport SI. Brain arachidonic and docosahexaenoic acid cascades
pathways in schizophrenia and mood disorders. Mol Psychiatry are selectively altered by drugs, diet and disease. Prostaglandins
2013;18:767‑73. Leukot Essent Fatty Acids 2008;79:153‑6.
33. Gos T, Schroeter ML, Lessel W, Bernstein HG, Dobrowolny H, 47. Cagnin A, Kassiou M, Meikle SR, Banati RB. Positron emission
Schiltz K, Bogerts B, Steiner J. S100B‑immunopositive astrocytes tomography imaging of neuroinflammation. Neurotherapeutics
and oligodendrocytes in the hippocampus are differentially afflicted 2007;4:443‑52.
in unipolar and bipolar depression: a postmortem study. J Psychiatr 48. Salter MW, Beggs S. Sublime microglia: expanding roles for the
Res 2013;47:1694‑9. guardians of the CNS. Cell 2014;158:15‑24.

262 Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015